IGF-1 regulates apoptosis of cardiac myocyte induced by osmotic-stress

Biochem Biophys Res Commun. 2000 Apr 21;270(3):1029-35. doi: 10.1006/bbrc.2000.2550.

Abstract

Insulin-like growth factor-1 (IGF-1) is a natural protectant of cardiac myocytes that has been shown to improve cardiac function. The role of IGF-1 in attenuating apoptosis induced by osmotic stress (sorbitol, SOR) or by other known apoptotic stimuli (doxorubicin, angiotensin II, and serum withdrawal) was determined in cultured cardiac myocytes. After 6 h of exposure to SOR, apoptosis was initiated, concomitant with a decrease in cell survival and increases in poly-[ADP-ribose] polymerase (PARP) degradation and DNA fragmentation. These effects were maximal after 24 h. IGF-1 partially attenuated apoptosis induced by sorbitol but not that induced by angiotensin II, doxorubicin, or serum withdrawal. In cells preincubated with IGF-1 before the addition of SOR, we detected an increase in the number of viable cells, a decrease in the generation of DNA fragments on agarose gel electrophoresis and in the percentage of positive TUNEL cells, and a reduction on PARP levels. These results suggest that IGF-1 prevents apoptosis induced by osmotic stress in cardiac myocytes but not apoptosis induced by doxorubicin and angiotensin II.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Angiotensin II / pharmacology
  • Animals
  • Animals, Newborn
  • Apoptosis / drug effects*
  • Apoptosis / physiology
  • Cell Survival / drug effects
  • Cells, Cultured
  • Culture Media, Serum-Free
  • Doxorubicin / pharmacology
  • Heart / drug effects
  • Heart Ventricles
  • Insulin-Like Growth Factor I / pharmacology*
  • Kinetics
  • Myocardium / cytology*
  • Osmolar Concentration
  • Rats
  • Rats, Sprague-Dawley
  • Sorbitol / pharmacology

Substances

  • Culture Media, Serum-Free
  • Angiotensin II
  • Sorbitol
  • Insulin-Like Growth Factor I
  • Doxorubicin